13F filing recap · Q2 2021

What did Abrams Capital Management buy in Q2 2021?

Reported stock-position changes between this filing and the previous one.

Stock value

$4.50B

Positions

Estimated turnover

2.2%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

CTLPCantaloupe Inc$24.79Mreported value+2.09M shares

Increased positions

CHNGChange Healthcare Inc.$321.27Mreported value+1.54M shares+12.5%

Reduced positions

PCGPG&E Corp$215.38Mreported value-1.57M shares-6.9%

Exited positions

CTLPCantaloupe Inc$22.28Mprior reported value-2.09M shares-100.0%